Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Teva wins FDA OK for crucial migraine drug

Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig

- PMLiVE

AZ prepares to file COPD triple, taking on rival GSK

Latest salvo in combination trials competition

- PMLiVE

Controversy grows around GP at Hand service after minister’s endorsement

Hancock says service should be rolled out across England

- PMLiVE

AZ nabs US approval for new leukaemia drug Lumoxiti

Adds to firm's growing oncology franchise

- PMLiVE

New data keeps AbbVie’s star pipeline therapies on track

Data showed 56% of patients on risankizumab were symptom free after a year’s treatment

- PMLiVE

‘Streamlined’ medicines regulation promised in ‘No Deal’ Brexit scenario

UK would miss out on new EU clinical trial regulations

Gilead Sciences

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Biopharma looks to genome editing platform to discover hepatitis B cure

- PMLiVE

Saatchi and Saatchi Wellness London launch IVF campaign

The advertising agency targets fair access to IVF treatments

- PMLiVE

Boehringer bolts on another immuno-oncology company

Acquires ViraTherapeutics in a €210m takeover deal

PM Society Digital Awards – the power of together

Our chief executive, Emma Statham, writes about the value of awards and the power of together.

Four Agency Worldwide

Sanofi reception

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

Dieter Weinand to be based in key US market

- PMLiVE

Shire’s bleeding disorder drug approved in Europe

Veyvondi for patients with rare disease von Willebrand disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links